Dahlia D An

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Topics

Network Analysis

Top Venues

Communications chemistry

Nature chemistry

Proceedings of the National Academy of Sciences of the United States of America

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Roger M Pallares, Dahlia D An, Solène Hébert, David Faulkner, Alex Loguinov, Michael Proctor, Jonathan A Villalobos, Kathleen A Bjornstad, Chris J Rosen, Christopher D Vulpe, Rebecca J Abergel
Delineating toxicity mechanisms associated with MRI contrast enhancement through a multidimensional toxicogenomic profiling of gadolinium. Molecular omics 18 (3) (2022)
Roger M Pallares, Dahlia D An, Solène Hébert, Alex Loguinov, Michael Proctor, Jonathan A Villalobos, Kathleen A Bjornstad, Chris J Rosen, Christopher D Vulpe, Rebecca J Abergel
Identifying Toxicity Mechanisms Associated with Early Lanthanide Exposure through Multidimensional Genome-Wide Screening. ACS omega 7 (38) (2022)
Roger M Pallares, David Faulkner, Dahlia D An, Solène Hébert, Alex Loguinov, Michael Proctor, Jonathan A Villalobos, Kathleen A Bjornstad, Chris J Rosen, Christopher D Vulpe, Rebecca J Abergel
Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials. Proceedings of the National Academy of Sciences of the United States of America 118 (18) (2021)
Roger M Pallares, Dahlia D An, Gauthier J P Deblonde, Birgitta Kullgren, Stacey S Gauny, Erin E Jarvis, Rebecca J Abergel
Efficient discrimination of transplutonium actinides by in vivo models. Chemical science 12 (14) (2021)
Andrew L Lakes, Dahlia D An, Stacey S Gauny, Camille Ansoborlo, Benjamin H Liang, Julian A Rees, Kristen D McKnight, Holger Karsunky, Rebecca J Abergel
Evaluating 225Ac and 177Lu Radioimmunoconjugates against Antibody-Drug Conjugates for Small-Cell Lung Cancer. Molecular pharmaceutics 17 (11) (2020)
Roger M Pallares, Peter Agbo, Xin Liu, Dahlia D An, Stacey S Gauny, Steven E Zeltmann, Andrew M Minor, Rebecca J Abergel
Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer. ACS applied materials & interfaces 12 (36) (2020)
Tyler A Bailey, Veronika Mocko, Katherine M Shield, Dahlia D An, Andrew C Akin, Eva R Birnbaum, Mark Brugh, Jason C Cooley, Johnathan W Engle, Michael Ernst-Heinrich Fassbender, Stacey S Gauny, Andrew L Lakes, Francois M Nortier, Ellen M O'Brien, Sara L Thiemann, Frankie D White, Christiaan Vermeulen, Stosh Anthony Kozimor, Rebecca J Abergel
Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics. Nature chemistry 13 (3) (2020)
Korey P Carter, Gauthier J P Deblonde, Trevor D Lohrey, Tyler A Bailey, Dahlia D An, Katherine M Shield, Wayne W Lukens, Rebecca J Abergel
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals. Communications chemistry 3 (1) (2020)
Korey P Carter, Gauthier J P Deblonde, Trevor D Lohrey, Tyler A Bailey, Dahlia D An, Katherine M Shield, Wayne W Lukens, Rebecca J Abergel
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals. Communications chemistry 3 (1) (2020)
Roger M Pallares, Dahlia D An, Pariswi Tewari, Elizabeth T Wang, Rebecca J Abergel
Rapid Detection of Gadolinium-Based Contrast Agents in Urine with a Chelated Europium Luminescent Probe. ACS sensors 5 (5) (2020)
Julian A Rees, Gauthier J-P Deblonde, Dahlia D An, Camille Ansoborlo, Stacey S Gauny, Rebecca J Abergel
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents. Scientific reports 8 (1) (2018)